Can India become global clinical trials hub? Industry leaders to discuss road ahead on 19th June
News

Can India become global clinical trials hub? Industry leaders to discuss road ahead on 19th June

Leading experts from AIIMS Kalyani, Syngene, Veeda Lifesciences, Lambda Therapeutic, DNDi, JSS Medical, KIHT, InoRx, ISCR and SIRO Clintech to discuss India’s readiness as preferred clinical research destination

  • By IPP Bureau | June 17, 2026

India's clinical research industry is entering a transformative phase, driven by regulatory reforms, growing investments in healthcare infrastructure, increasing global outsourcing opportunities, and the adoption of digital and decentralized trial models.

To explore how the country can capitalize on this momentum, Indian Pharma Post will host a high-level E-Conference titled "Can India Become a Global Clinical Trials Hub?" on June 19, 2026, at 3:00 PM IST.

The webinar will bring together distinguished leaders from academia, industry, clinical research organizations, and healthcare institutions to discuss the opportunities and challenges shaping the future of clinical trials in India.

The expert panel includes Prof. Y. K. Gupta, President, AIIMS Kalyani; Dr. Mrinal Kammili, Head of Translational and Clinical Research, Syngene International; Mr. Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences; Dr. Pranjal P. Bordoloi, Senior Vice President – Late Phase Operations, Lambda Therapeutic Research Limited; and Dr. Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi.

Also, joining the panel are Dr. Renu Razdan, Senior Vice President, JSS Medical Research India; Dr. Kavita Kachroo, Chief Operating Officer, Kalam Institute of Health Technology; Dr. Avi Kulkarni, CEO & Head of CRO, InoRx Limited; Dr. Sanish Davis, Executive Committee Member, ISCR; and Dr. Somesh Bolegave, Head – Biometrics, Regulatory and Medical Services, SIRO Clintech.

The virtual discussion moderated by Rahul Koul, Editor, Indian Pharma Post will focus on India's position in the global clinical trials market, strengthening trial infrastructure, ensuring data integrity and regulatory compliance.

The session will also discuss enhancing patient participation, adopting hybrid and technology-enabled trial models, and building a globally competitive clinical research ecosystem.

Healthcare professionals, pharmaceutical and biotechnology executives, researchers, investigators, CRO leaders, policymakers, and students are encouraged to register as delegates and participate in this insightful discussion.

Registeration Link

Date: June 19, 2026
Time: 3:00 PM - 4:30 PM IST
Organizer: Indian Pharma Post

Register now to gain insights from some of the most influential voices shaping the future of clinical research in India. 

Other Related stories

Startup

Digitization